School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.
Bioorg Med Chem Lett. 2013 May 1;23(9):2543-7. doi: 10.1016/j.bmcl.2013.03.005. Epub 2013 Mar 13.
In the present investigation, 16 new rotundic acid (RA) derivatives modified at the C-3, C-23 and C-28 positions were synthesized. The cytotoxicities of the derivatives were evaluated against HeLa, A375, HepG2, SPC-A1 and NCI-H446 human tumor cell lines by MTT assay. Among these derivatives, compounds 4-7 exhibited stronger cell growth inhibitory than RA and compound 4 was found to be the best inhibition activity on five human tumor cell lines with IC50 <10 μM. The apoptosis mechanism of compound 4 in HeLa cells was investigated by western blot analysis. The results indicated that compound 4 could induce apoptosis through increasing protein expression of cleaved caspase-3 and Bax, and decreasing protein expression of Bcl-2. In summary, the present work suggests that compound 4 might serve as an effective chemotherapeutic candidate.
在本研究中,合成了 16 种在 C-3、C-23 和 C-28 位修饰的新轮环藤酸(RA)衍生物。通过 MTT 法评估了衍生物对 HeLa、A375、HepG2、SPC-A1 和 NCI-H446 人肿瘤细胞系的细胞毒性。在这些衍生物中,化合物 4-7 对 RA 表现出更强的细胞生长抑制作用,而化合物 4 对五种人肿瘤细胞系的抑制活性最好,IC50<10 μM。通过 Western blot 分析研究了化合物 4 在 HeLa 细胞中的凋亡机制。结果表明,化合物 4 可通过增加裂解 caspase-3 和 Bax 的蛋白表达,降低 Bcl-2 的蛋白表达,诱导细胞凋亡。总之,本研究表明化合物 4 可能是一种有效的化疗候选药物。